GSK ponders legal action on KFDA's administrative disposition

Published: 2004-11-26 06:59:00

Updated: 2004-11-26 06:59:00

GlaxoSmithKline said it is now reviewing various ways to run counter to the November 23 administrative disposition for false ads of its flu vaccine Fluarix, meted out by the Korea Food and Drug Administration, adding it is quite regretful and disappointed that the FDA imposed a certain amount of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK